Cachet Pharmaceutical Co., Ltd.

SZSE:002462.SZ

13.64 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 29,996.2426,219.7925,625.61923,256.13622,186.57317,959.88514,238.910,971.5778,199.8325,572.1523,544.2752,554.0731,801.381,341.6711,133.56965.222662.903
Cost of Revenue 28,018.52724,112.23723,484.86221,121.97219,916.2216,122.28912,858.2129,774.3797,146.6984,854.2063,206.8882,332.0131,630.6431,171.51980.659829.387555.713
Gross Profit 1,977.7132,107.5532,140.7572,134.1632,270.3531,837.5961,380.6881,197.1981,053.134717.946337.387222.06170.737170.161152.901135.834107.19
Gross Profit Ratio 0.0660.080.0840.0920.1020.1020.0970.1090.1280.1290.0950.0870.0950.1270.1350.1410.162
Reseach & Development Expenses 00001.5000000000000
General & Administrative Expenses 68.01263.55769.26861.75765.64967.68457.71144.90940.42827.66910.8318.355.7624.3913.5823.0916.14
Selling & Marketing Expenses 724.907834.817800.312678.789895.048628.631451.265410.164428.602312.059148.73698.8885.16380.46674.22364.6263.432
SG&A 792.92898.373869.58740.546960.697696.315508.975455.074469.03339.729159.567107.2390.92584.85777.80567.7169.572
Other Expenses -12.014263.656234.163192.837196.478-2.318-2.5097.0024.0434.01829.618-0.06515.748-0.4170.1254.6292.892
Operating Expenses 1,072.0551,162.0291,103.743933.3841,157.175859.091638.692563.391562.718403.676196.091134.703110.601106.24496.25985.57888.6
Operating Income 556.362936.891830.7661,194.95891.104777.169631.588545.289399.05406.548164.68991.74969.65665.26156.35950.743212.319
Operating Income Ratio 0.0190.0360.0320.0510.040.0430.0440.050.0490.0730.0460.0360.0390.0490.050.0530.32
Total Other Income Expenses Net -350.376-291.985-6.787-380.643-3.554-203.654-112.917-81.564-87.37696.2552.9954.16825.2690.927-0.1664.997196.519
Income Before Tax 555.282644.906823.979814.307887.55774.851629.079552.243403.04410.52194.29191.52585.40564.84556.47655.253215.108
Income Before Tax Ratio 0.0190.0250.0320.0350.040.0430.0440.050.0490.0740.0550.0360.0470.0480.050.0570.324
Income Tax Expense 178.748176.594222.1223.404227.747204.239159.635142.244101.695104.09847.64822.65421.57615.90113.93513.66932.128
Net Income 250.06468.313601.879590.904659.802327.633263.642223.1172.976228.06130.16965.2163.68348.54242.41841.357182.625
Net Income Ratio 0.0080.0180.0230.0250.030.0180.0190.020.0210.0410.0370.0260.0350.0360.0370.0430.275
EPS 0.861.612.062.032.531.311.050.890.720.950.540.270.270.240.230.231.01
EPS Diluted 0.861.612.062.032.531.311.050.890.720.950.540.270.270.240.230.231.01
EBITDA 1,118.3611,163.641,239.0481,370.8611,195.2811,015.103782.961670.865520.144477.503221.218108.02392.1878.12166.70559.54330.073
EBITDA Ratio 0.0370.0440.0480.0590.0540.0570.0550.0610.0630.0860.0620.0420.0510.0580.0590.0620.045